Entera Bio Ltd.

NASDAQ: ENTX · Real-Time Price · USD
1.99
0.02 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.00
0.50%
After-hours: Aug 15, 2025, 07:57 PM EDT

Entera Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-9.54M -8.89M -13.07M -12.19M
Depreciation & Amortization
46K 56K 64K 53K
Stock-Based Compensation
2.56M 1.69M 2.25M 1.86M
Other Working Capital
189K -507K -1.62M 1.33M
Other Non-Cash Items
-5K n/a -78K 18K
Deferred Income Tax
14K 29K 174K -217K
Change in Working Capital
112K -195K -1.83M 1.41M
Operating Cash Flow
-6.82M -7.31M -12.5M -9.06M
Capital Expenditures
-3K -17K -47K -17K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -55K n/a
Investing Cash Flow
-3K -17K -102K -17K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -580K 13K 3.58M
Financial Cash Flow
4.48M 6.04M 13K 25.38M
Net Cash Flow
-2.35M -1.29M -12.59M 16.3M
Free Cash Flow
-6.82M -7.33M -12.55M -9.08M